Risk Comparison · Cached SEC Snapshots
AAPL vs CBIO — Structural Risk Comparison
AAPL
Apple Inc.
AA
MODERATE / CAUTION
Score: 75%
VS
CBIO
CRESCENT BIOPHARMA, INC.
C
MODERATE / CAUTION
Score: 17%
STRUCTURAL RISK ANALYSIS · DETERMINISTIC
CBIO SHOWS HIGHER STRUCTURAL RISK
CBIO has 937.1 fewer months of cash runway (61.9 mo vs 999.0 mo).
METRIC
AAPL
CBIO
SPREAD
Doomsday Clock
999.0 mo▲
61.9 mo▼
937.1 mo
Dilution Risk
-2.3 / 100▲
0.0 / 100▼
2.3 pts
Altman Z-Score
1.13▲
0.74▼
0.39
Operating Cash Flow
$53.92B▲
-$8.9M▼
—
Net Income
$42.10B▲
-$23.3M▼
—
Current Ratio
0.97x▼
13.78x▲
—
Retained Earnings
-$2.18B▼
-$195.1M▲
—
Contagion Watch
Other tickers the Risk Sentinel just flagged
Is your portfolio hiding a toxic S-3?
Run any ticker through the same Risk Sentinel scan — free.
Educational analysis only. Not financial advice. Comparison uses cached SEC EDGAR data and may contain inaccuracies. AI systems are fallible. Always verify against primary filings on
SEC EDGAR
and consult a licensed advisor before making investment decisions.